Monopar Therapeutics (MNPR) Institutional Ownership $98.57 +0.05 (+0.05%) Closing price 10/8/2025 04:00 PM EasternExtended Trading$98.40 -0.17 (-0.18%) As of 10/8/2025 07:24 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Monopar Therapeutics (NASDAQ:MNPR)CurrentInstitutional OwnershipPercentage1.83%Number ofInstitutional Buyers(last 12 months)17TotalInstitutional Inflows(last 12 months)$61.60MNumber ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$1.08M Get MNPR Insider Trade Alerts Want to know when executives and insiders are buying or selling Monopar Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data MNPR Institutional Buying and Selling by Quarter Monopar Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/15/2025Bank of America Corp DE2,109$75K0.0%-14.9%0.034% 8/14/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.2,222$80K0.0%N/A0.036% 8/13/2025Affinity Asset Advisors LLC67,500$2.42M0.3%+8.9%1.104% 8/13/2025New York State Common Retirement Fund2,900$104K0.0%N/A0.047% 8/12/2025Rhumbline Advisers5,850$209K0.0%N/A0.096% 8/12/2025JPMorgan Chase & Co.1,921$69K0.0%+1,821.0%0.031% 8/8/2025Police & Firemen s Retirement System of New Jersey964$34K0.0%N/A0.016% 8/8/2025Geode Capital Management LLC96,919$3.47M0.0%+99.7%1.584% 7/31/2025AlphaQuest LLC1,784$64K0.0%+46.8%0.029% 6/27/2025Goldman Sachs Group Inc.18,480$673K0.0%N/A0.302% Get the Latest News and Ratings for MNPR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Monopar Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 5/19/2025Jane Street Group LLC10,357$377K0.0%N/A0.169% 5/16/2025Goldman Sachs Group Inc.18,480$673K0.0%N/A0.302% 5/16/2025ADAR1 Capital Management LLC100,774$3.67M0.7%-22.5%1.648% 5/15/2025OMERS ADMINISTRATION Corp9,000$328K0.0%N/A0.147% 5/14/2025Affinity Asset Advisors LLC62,000$2.26M0.2%N/A1.014% 5/14/2025AlphaQuest LLC1,215$44K0.0%N/A0.020% 4/23/2025Gerber LLC5,601$204K0.2%N/A0.092% 2/17/2025Point72 Asset Management L.P.167,892$3.69M0.0%N/A2.752% 2/17/2025Janus Henderson Group PLC1,046,899$23.44M0.0%N/A17.162% 2/14/2025RA Capital Management L.P.511,207$11.25M0.1%N/A8.380% 2/14/2025Adage Capital Partners GP L.L.C.599,195$13.18M0.0%N/A9.823% 2/13/2025ADAR1 Capital Management LLC130,037$2.86M0.6%N/A2.132% 2/12/2025Geode Capital Management LLC38,596$849K0.0%+174.4%0.633% 2/12/2025JPMorgan Chase & Co.2,037$45K0.0%N/A0.033% 10/31/2023Windsor Advisory Group LLC89,974$56K0.1%N/A0.635% 8/13/2021Geode Capital Management LLC28,761$169K0.0%+9.0%0.229% 8/13/2021Vanguard Group Inc.97,462$574K0.0%+116.2%0.775% (Data available from 1/1/2016 forward) MNPR Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of MNPR shares? During the previous two years, 19 institutional investors and hedge funds held shares of Monopar Therapeutics. The most heavily invested institutionals were Janus Henderson Group PLC ($23.44M), Adage Capital Partners GP L.L.C. ($13.18M), RA Capital Management L.P. ($11.25M), Point72 Asset Management L.P. ($3.69M), ADAR1 Capital Management LLC ($3.67M), Geode Capital Management LLC ($3.47M), and Affinity Asset Advisors LLC ($2.42M).Learn more on Monopar Therapeutics' institutional investors. What percentage of Monopar Therapeutics' stock is owned by institutional investors? 1.83% of Monopar Therapeutics' stock is owned by institutional investors. Learn more on MNPR's institutional investor holdings. Which institutional investors have been buying Monopar Therapeutics' stock? Of the 18 institutional investors that purchased Monopar Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Janus Henderson Group PLC ($1.05M), Adage Capital Partners GP L.L.C. ($599.20K), RA Capital Management L.P. ($511.21K), Point72 Asset Management L.P. ($167.89K), ADAR1 Capital Management LLC ($130.04K), Windsor Advisory Group LLC ($89.97K), and Geode Capital Management LLC ($72.91K). How much institutional buying is happening at Monopar Therapeutics? Institutional investors have bought a total of 2,675,135 shares in the last 24 months. This purchase volume represents approximately $61.60M in transactions. Which of Monopar Therapeutics' major shareholders have been selling company stock? The following institutional investors have sold Monopar Therapeutics stock in the last 24 months: ADAR1 Capital Management LLC ($29.26K), and Bank of America Corp DE ($369.00). How much institutional selling is happening at Monopar Therapeutics? Institutional investors have sold a total of 29,632 shares in the last 24 months. This volume of shares sold represents approximately $1.08M in transactions. Related Companies Dyne Therapeutics Major Shareholders Vera Therapeutics Major Shareholders Sarepta Therapeutics Major Shareholders Apogee Therapeutics Major Shareholders Intellia Therapeutics Major Shareholders Harrow Major Shareholders Aurinia Pharmaceuticals Major Shareholders Immunocore Major Shareholders Edgewise Therapeutics Major Shareholders Twist Bioscience Major Shareholders This page (NASDAQ:MNPR) was last updated on 10/9/2025 by MarketBeat.com Staff From Our PartnersBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Monopar Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Monopar Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
